437 related articles for article (PubMed ID: 26098879)
1. Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.
Sodhi K; Puri N; Favero G; Stevens S; Meadows C; Abraham NG; Rezzani R; Ansinelli H; Lebovics E; Shapiro JI
PLoS One; 2015; 10(6):e0128648. PubMed ID: 26098879
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
[TBL] [Abstract][Full Text] [Related]
3. The Role of Heme Oxygenase 1 in the Protective Effect of Caloric Restriction against Diabetic Cardiomyopathy.
Waldman M; Nudelman V; Shainberg A; Zemel R; Kornwoski R; Aravot D; Peterson SJ; Arad M; Hochhauser E
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100876
[TBL] [Abstract][Full Text] [Related]
4. Beneficial Role of HO-1-SIRT1 Axis in Attenuating Angiotensin II-Induced Adipocyte Dysfunction.
Lakhani HV; Zehra M; Pillai SS; Puri N; Shapiro JI; Abraham NG; Sodhi K
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261892
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
6. Sirt1 mediates the effect of the heme oxygenase inducer, cobalt protoporphyrin, on ameliorating liver metabolic damage caused by a high-fat diet.
Liu X; Gao Y; Li M; Geng C; Xu H; Yang Y; Guo Y; Jiao T; Fang F; Chang Y
J Hepatol; 2015 Sep; 63(3):713-21. PubMed ID: 26026874
[TBL] [Abstract][Full Text] [Related]
7. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
[TBL] [Abstract][Full Text] [Related]
8. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
9. Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression.
Ryu J; Kim E; Kang MK; Song DG; Shin EA; Lee H; Jung JW; Nam SH; Kim JE; Kim HJ; Son T; Kim S; Kim HY; Lee JW
J Pathol; 2021 Jan; 253(1):55-67. PubMed ID: 32918742
[TBL] [Abstract][Full Text] [Related]
10. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
11. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPARα/FoxO1 signaling pathway.
Zhang W; Sun Y; Liu W; Dong J; Chen J
Int J Mol Med; 2019 Mar; 43(3):1271-1280. PubMed ID: 30664220
[TBL] [Abstract][Full Text] [Related]
12. Betulin prevents high fat diet-induced non-alcoholic fatty liver disease by mitigating oxidative stress and upregulating Nrf2 and SIRT1 in rats.
Farage AE; Abdo W; Osman A; Abdel-Kareem MA; Hakami ZH; Alsulimani A; Bin-Ammar A; Alanazi AS; Alsuwayt B; Alanazi MM; Antar SA; Kamel EM; Mahmoud AM
Life Sci; 2023 Jun; 322():121688. PubMed ID: 37030617
[TBL] [Abstract][Full Text] [Related]
13. Folic acid attenuates high-fat diet-induced steatohepatitis
Xin FZ; Zhao ZH; Zhang RN; Pan Q; Gong ZZ; Sun C; Fan JG
World J Gastroenterol; 2020 May; 26(18):2203-2220. PubMed ID: 32476787
[TBL] [Abstract][Full Text] [Related]
14. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
15. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
Li Q; Tan JX; He Y; Bai F; Li SW; Hou YW; Ji LS; Gao YT; Zhang X; Zhou ZH; Yu Z; Fang M; Gao YQ; Li M
Int J Biol Sci; 2022; 18(4):1594-1611. PubMed ID: 35280674
[No Abstract] [Full Text] [Related]
16. Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.
Han X; Ding C; Zhang G; Pan R; Liu Y; Huang N; Hou N; Han F; Xu W; Sun X
Biochem Biophys Res Commun; 2020 May; 525(4):895-901. PubMed ID: 32171530
[TBL] [Abstract][Full Text] [Related]
17. A conjugated fatty acid present at high levels in bitter melon seed favorably affects lipid metabolism in hepatocytes by increasing NAD(+)/NADH ratio and activating PPARα, AMPK and SIRT1 signaling pathway.
Chen GC; Su HM; Lin YS; Tsou PY; Chyuan JH; Chao PM
J Nutr Biochem; 2016 Jul; 33():28-35. PubMed ID: 27260465
[TBL] [Abstract][Full Text] [Related]
18. Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21.
Hinds TD; Sodhi K; Meadows C; Fedorova L; Puri N; Kim DH; Peterson SJ; Shapiro J; Abraham NG; Kappas A
Obesity (Silver Spring); 2014 Mar; 22(3):705-12. PubMed ID: 23839791
[TBL] [Abstract][Full Text] [Related]
19. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
20. Protective role of HO-1 and carbon monoxide in ethanol-induced hepatocyte cell death and liver injury in mice.
Bakhautdin B; Das D; Mandal P; Roychowdhury S; Danner J; Bush K; Pollard K; Kaspar JW; Li W; Salomon RG; McMullen MR; Nagy LE
J Hepatol; 2014 Nov; 61(5):1029-37. PubMed ID: 24946281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
